Romero Rocío, Penas Rocío, García-Conde Ana, Llombart Pilar, Pérez Sandra, Marco José H
Instituto Valenciano de Oncología (IVO).
Psicothema. 2020 Nov;32(4):508-515. doi: 10.7334/psicothema2019.320.
The aim of this study is to analyse whether MBCT will reduce the general level of psychopathology, increase the quality of life, and increase meta-knowledge about their emotional state in Spanish participants with cancer.
The sample consisted of n = 88 Spanish oncology patients. This was a non-randomized, two-group (experimental vs waiting list) trial conducted in a naturalistic setting. We evaluated psychological distress (BSI-18), quality of life (FACT-G), and meta-knowledge of emotions (TMMS-24).
The participants who received the MBCT treatment improved more than the control group in distress (F= 6.79; p = .01, BSI-18), depression (F= 8.38; p = .005 ), quality of life -physical health (F = 5.56; p = .02), emotional state (F = 7.06; p= .01), and functional capacity (F = 7.98; p = .006), as well as meta-knowledge about their emotional state (F = 35.4; p = .01), and its subscales of perception, (F = 8.95; p = .004), comprehension, (F= 16.06; p = .01), and repair (F = 15.67; p = .01).
The Bartley MBCT program was feasible and showed promise in improving general psychopathology (depression), improving patients' quality of life, and increasing meta-knowledge about their emotional state.
本研究旨在分析正念认知疗法(MBCT)是否会降低西班牙癌症患者的心理病理学总体水平、提高生活质量并增加其对自身情绪状态的元认知。
样本包括88名西班牙肿瘤患者。这是一项在自然环境中进行的非随机、两组(实验组与等待名单组)试验。我们评估了心理困扰(简明症状量表-18,BSI-18)、生活质量(癌症治疗功能评价量表-通用版,FACT-G)以及情绪元认知(情绪管理量表-24,TMMS-24)。
接受正念认知疗法治疗的参与者在困扰(F = 6.79;p = 0.01,BSI-18)、抑郁(F = 8.38;p = 0.005)、生活质量-身体健康(F = 5.56;p = 0.02)、情绪状态(F = 7.06;p = 0.01)和功能能力(F = 7.98;p = 0.006)方面的改善程度均高于对照组,在对自身情绪状态的元认知(F = 35.4;p = 0.01)及其感知(F = 8.95;p = 0.004)、理解(F = 16.06;p = 0.01)和修复(F = 15.67;p = 0.01)子量表方面也是如此。
巴特利正念认知疗法项目是可行的,在改善总体心理病理学(抑郁)、提高患者生活质量以及增加对自身情绪状态的元认知方面显示出前景。